Kuntz KM - Search Results

1

Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.

Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ. Punglia RS, et al. Among authors: kuntz km. J Clin Oncol. 2005 Aug 1;23(22):5178-87. doi: 10.1200/JCO.2005.02.964. Epub 2005 Jul 5. J Clin Oncol. 2005. PMID: 15998905

2

HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.

Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC. Elkin EB, et al. Among authors: kuntz km. J Clin Oncol. 2004 Mar 1;22(5):854-63. doi: 10.1200/JCO.2004.04.158. J Clin Oncol. 2004. PMID: 14990641

3

The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.

Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ. Punglia RS, et al. Among authors: kuntz km. Cancer. 2006 Jun 15;106(12):2576-82. doi: 10.1002/cncr.21919. Cancer. 2006. PMID: 16703595 Free article.

4

Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.

Guadagnolo BA, Punglia RS, Kuntz KM, Mauch PM, Ng AK. Guadagnolo BA, et al. Among authors: kuntz km. J Clin Oncol. 2006 Sep 1;24(25):4116-22. doi: 10.1200/JCO.2006.07.0409. J Clin Oncol. 2006. PMID: 16943528

5

Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.

Chen AB, Punglia RS, Kuntz KM, Mauch PM, Ng AK. Chen AB, et al. Among authors: kuntz km. J Clin Oncol. 2009 Nov 10;27(32):5383-9. doi: 10.1200/JCO.2009.22.8460. Epub 2009 Sep 14. J Clin Oncol. 2009. PMID: 19752333 Free PMC article.

6

Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.

Punglia RS, Kuntz KM, Lee JH, Recht A. Punglia RS, et al. Among authors: kuntz km. J Clin Oncol. 2003 Jun 15;21(12):2260-7. doi: 10.1200/JCO.2003.07.072. J Clin Oncol. 2003. PMID: 12805324

7

Laparotomy versus no laparotomy in the management of early-stage, favorable-prognosis Hodgkin's disease: a decision analysis.

Ng AK, Weeks JC, Mauch PM, Kuntz KM. Ng AK, et al. Among authors: kuntz km. J Clin Oncol. 1999 Jan;17(1):241-52. doi: 10.1200/JCO.1999.17.1.241. J Clin Oncol. 1999. PMID: 10458239

8

Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease.

Ng AK, Weeks JC, Mauch PM, Kuntz KM. Ng AK, et al. Among authors: kuntz km. J Clin Oncol. 1999 Nov;17(11):3577-85. doi: 10.1200/JCO.1999.17.11.3577. J Clin Oncol. 1999. PMID: 10550157 Review.

9

Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.

Schrag D, Kuntz KM, Garber JE, Weeks JC. Schrag D, et al. Among authors: kuntz km. JAMA. 2000 Feb 2;283(5):617-24. doi: 10.1001/jama.283.5.617. JAMA. 2000. PMID: 10665701

10

Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs.

Elkin EB, Weinstein MC, Kuntz KM, Bunnell CA, Weeks JC. Elkin EB, et al. Among authors: kuntz km. Breast Cancer Res Treat. 2005 Sep;93(1):25-34. doi: 10.1007/s10549-005-3380-2. Breast Cancer Res Treat. 2005. PMID: 16184455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters